Cambridge University Hospitals NHS Foundation Trust

The Cambridge University Hospitals NHS Foundation Trust incorporates Addenbrooke's Hospital in Cambridge http://www.cuh.org.uk/

View Trust Services

This trust offers the following services:

  • Acute services:
    • On-site bowel stenting facilities
  • Diagnostic and pre-operative services:
    • On-site PET-CT facilities
    • On-site Cardio-Pulmonary Exercise Testing (CPET) facilities
    • Routine Genetic Testing for Lynch Syndrome
  • Surgical services:
    • On-site hepatobiliary surgical team
  • Advanced disease services:
    • Dedicated Specialist Advanced Nurse
    • Dedicated Specialist Advanced Outpatient Clinic
    • Complex vascular reconstruction
    • Distal sacrectomy
    • Extended lymphadenectomy
  • Support service facilities:
    • Dedicated nurses for ERAS services

Data Quality

All Patients: Trust Network National
Number of patients in Audit 352 2310 35779
Case ascertainment (%) Good Good Good
Data completeness of:
– Pre-treatment TNM (%) 86 86 86
– Performance status (%) 100 98 89
Patients having major resection: Trust Network National
Number of patients in Audit 195 1175 19631
ASA grade 1 (%) 3 7 9
ASA grade 2 (%) 65 55 53
ASA grade 3 (%) 29 36 31
ASA grade 4+ (%) 3 2 2
ASA grade not recorded (%) 1 2 4
Data completeness of:
7 Audit items for risk-adjustment (%) 99 88 87

Key:

> 80%
50 - 80%
< 50%

Management of all patients

All Patients: Trust Network National
Number of patients in Audit 352 2310 35779
Seen by Clinical Nurse Specialist (%) 100 86 88

Management of patients having major resection

Patients having major resection: Trust Network National
Number of patients in Audit 195 1175 19614
Distant metastases (%) 6 4 5
Urgent or emergency surgery (%) 10 12 15
At least 12 lymph nodes excised (%) 94 81 84
Laparoscopic surgery attempted (%) 72 68 72
Risk-adjusted length of stay > 5 days (%) 70 58 55
Patients having major resection for stage III colon cancer: Trust Network National
Number of patients in audit 117 N/A 10747
Adjuvant chemotherapy (%) 65 N/A 62
Patients receiving chemotherapy after major resection for stage III colon cancer: Trust Network National
Number of patients in audit 77 N/A 6608
Severe acute toxicity after adjuvant chemotherapy (%) 28 N/A 22

Rectal cancer patients

Patients having major resection: Trust Network National
Number of patients in Audit 45 N/A 4251
Neoadjuvant therapy (%) 72 N/A 33
Circumferential resection margin: Recorded (%) 100 86 89
Circumferential resection margin: Negative (%) 98 80 83
Rectal volume 60 N/A 4377
Patients in APER/Hartmanns estimate: Trust Network National
Number of patients in APER/Hartmanns estimate 229 1244 19644
APER/Hartmanns (%) 38 35 37

Compare trust outcomes